Enb Therapeutics, Inc. announced it raised $2.29 Million in an initial filing from an offering of $9.09 Million

Sep 21, 2018•almost 7 years ago

Amount Raised

$2.29 Million

Round Type

seed

New YorkBiotechnology

Company Information

Company

ENB Therapeutics, Inc.

Location

C/O LAUNCHLABS

New York, New York, United States

About

ENB Therapeutics is developing therapies to break barriers that prevent the majority of patients from responding to immunotherapy agents.